Yoga for Treatment of Hot Flashes
1 other identifier
interventional
12
1 country
1
Brief Summary
The Yoga for Treatment of Hot Flashes and Menopausal Symptoms is an uncontrolled pilot clinical trial to determine the feasibility of recruitment and of evaluating yoga for the relief of menopausal hot flashes in 12 peri- or postmenopausal women. Participants will attend an Introductory Yoga Workshop, 8 yoga training sessions in 8 weeks, be assessed clinically before, during, and after training and contacted by telephone 3 months later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2005
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2005
CompletedFirst Submitted
Initial submission to the registry
January 25, 2006
CompletedFirst Posted
Study publicly available on registry
January 27, 2006
CompletedNovember 8, 2023
November 1, 2023
January 25, 2006
November 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of number and severity of hot flashes will be summarized by the sample averages.
Interventions
Eligibility Criteria
You may qualify if:
- Self-report ≥4 moderate to severe hot flashes per day or ≥ 30 moderate to severe hot flashes per week.
- Successful completion of a Hot Flash Diary.
- Able and willing to attend yoga training sessions, maintain yoga logs, and practice yoga at home.
You may not qualify if:
- Inability to sign an informed consent or fill out questionnaires.
- Use of other treatments for hot flashes (estrogens, progestins, clonidine, selective serotonin reuptake inhibitors,relaxation techniques or acupuncture) within 4 weeks of enrollment in the trial and do not agree to refrain from using these therapies for the duration of the trial.
- Use of raloxifene or tamoxifen within three months of enrollment.
- Any condition that, in the investigator's opinion, would preclude the participant from being able to understand and follow the yoga training or from completing the trial, including severe illness, plans to move, substance abuse, significant psychiatric problems, or dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSF Women's Health Clinical Research Center
San Francisco, California, 94115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deborah Grady, MD, MPH
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 25, 2006
First Posted
January 27, 2006
Study Start
September 1, 2005
Study Completion
December 1, 2005
Last Updated
November 8, 2023
Record last verified: 2023-11